Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer - Secondary analysis of the randomised phase 3 CONVERT trial

Autor: Fiona H Blackhall, Andrea Bezjak, Hitesh Mistry, N. Pourel, Fabio Gomes, Pierre Fournel, Jan P. van Meerbeeck, Corinne Faivre-Finn

Publikováno v: Gomes, F, Faivre-Finn, C, Mistry, H, Bezjak, A, Pourel, N, Fournel, P, Meerbeeck, J V & Blackhall, F 2021, ' Safety of G-CSF with concurrent chemo-radiotherapy in limited-stage small cell lung cancer-Secondary analysis of the randomised phase 3 CONVERT trial ', Lung Cancer, vol. 153, pp. 165-170 . https://doi.org/10.1016/j.lungcan.2021.01.025
Lung cancer: journal of the International Association for the Study of Lung Cancer

Objectives: The use of granulocyte colony-stimulating factors (G-CSF) during concurrent chemo-radiotherapy (cCTRT) for small cell lung cancer is not recommended by the American Society of Clinical Oncology due to safety concerns. This secondary analy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58b1ae1aec935b6e921c8fc784624298
https://doi.org/10.1016/j.lungcan.2021.01.025

Quality/risk management system in radiotherapy: Changes afoot

Autor: N. Pourel, C. Meyrieux, A. Lisbona

Publikováno v: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 26(1-2)

The French sanitary and regulatory context in which radiotherapy centres are comprised is evolving. Risk and quality management systems are currently adapting to these evolutions. The French nuclear safety agency (ASN) decision of July 1st 2008 on qu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5d432a7d9f05d25c5f28532bbd362a1
https://pubmed.ncbi.nlm.nih.gov/34953695

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Un essai international randomisé, comparant la radiothérapie conformationnelle postopératoire (RPO) à l’absence de RPO, chez des patients atteints d’un cancer bronchique non à petites cellules (CBNPC) complètement réséqué et avec envahissement ganglionnaire médiastinal N2. Première analyse de l’essai Lung ART (IFCT-0503, UK NCRI, SAKK)

Autor: Fabrice Barlesi, N. Pourel, Eric Dansin, Delphine Antoni, O. Riesterer, J. Madeleine, Delphine Lerouge, P. Boisselier, K. Peignaux, A. Bardet, Amaury Paumier, F. Thillays, Ursula Nestle, C. Le Pechoux, A. Larrouy, Corinne Faivre-Finn, B. Lamezec, Eric Pichon, Armelle Lavolé, G. Zalcman

Publikováno v: Revue des Maladies Respiratoires Actualités. 13:9-10

Introduction La radiotherapie post-operatoire (RPO) est un sujet de discussion depuis la meta-analyse montrant que la RPO pouvait etre deletere en particulier chez les patients (pts) pN0 et pN1. Cependant, la question restait ouverte pour les pts pN2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::42675a250584b6988359d37d523c3c90
https://doi.org/10.1016/j.rmra.2020.11.013